Terms: = Skin cancer AND TRIM33, RFG7, 51592, ENSG00000197323, Q9UPN9, TF1G, FLJ32925, TIF1G, PTC7, TIFGAMMA, TIF1GAMMA AND Diagnosis
7 results:
1. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract] [Full Text] [Related]
2. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under diagnosis of Chronic Eczema: A Case Report.
Yoshida S; Matsumoto H; Fujita Y; Yokose K; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Yaguchi T; Aita T; Kusano M; Yamamoto T; Watanabe H; Migita K
Tohoku J Exp Med; 2022 Apr; 256(4):303-308. PubMed ID: 35296571
[TBL] [Abstract] [Full Text] [Related]
3. A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast cancer.
Piras M; Panebianco M; Garibaldi M; Roberto M; Merlonghi G; Pellegrini P; Marchetti P
Curr Oncol; 2021 May; 28(3):1957-1961. PubMed ID: 34073827
[TBL] [Abstract] [Full Text] [Related]
4. Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen.
De Vooght J; Vulsteke JB; De Haes P; Bossuyt X; Lories R; De Langhe E
Rheumatology (Oxford); 2020 Mar; 59(3):469-477. PubMed ID: 31883334
[TBL] [Abstract] [Full Text] [Related]
5. Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
Wolstencroft PW; Casciola-Rosen L; Fiorentino DF
JAMA Dermatol; 2018 Oct; 154(10):1199-1203. PubMed ID: 30140893
[TBL] [Abstract] [Full Text] [Related]
6. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
Kubeček O; Soukup T; Paulík A; Kopecký J
BMC Cancer; 2016 Aug; 16(1):684. PubMed ID: 27561848
[TBL] [Abstract] [Full Text] [Related]
7. Advances in serological diagnostics of inflammatory myopathies.
Benveniste O; Stenzel W; Allenbach Y
Curr Opin Neurol; 2016 Oct; 29(5):662-73. PubMed ID: 27538058
[TBL] [Abstract] [Full Text] [Related]
